by Emily Sparrow | Dec 3, 2015
On Tuesday, December 8th at 1:00pm. EST, greenlight.guru, Pearl Pathways’ strategic partner for eQMS, will be offering a webinar about how to manage risk in new product development, specific to medical devices. By attending this webinar you will learn the in’s and...
by Emily Sparrow | Dec 2, 2015
Fierce Medical Devices announced the release of their list of top women in medical devices in 2015. The list is comprised of ten women across the nation of who have made an impact in the medical device industry this year. To access the article and list, click...
by Emily Sparrow | Dec 2, 2015
The US Food and Drug Administration (FDA) is planning to develop ways to better determine accuracy of predictions from regulatory testing of next-generation sequencing (NGS), according to FDA Commissioner nominee Robert Califf. Michael Mezher states that FDA has been...
by Emily Sparrow | Nov 20, 2015
Pearl Pathways is excited to announce its growth and expansion into a second location in College Station, Texas. The new office will be a part of The Garage, located within the Texas A&M Institute for Preclinical Studies (TIPS) building. The Garage is supported...
by Emily Sparrow | Nov 18, 2015
The U.S. Food and Drug Administration (FDA) has been called by multiple organizations to clarify its “regulatory flexibility” with orphan drug reviews, according to Michael Mehzer, RAPS. FDA released a draft guidance in August addressing the most common issues faced...
